gp100 (619-627)

gp100 (619-627) is a synthetic peptide fragment corresponding to amino acids 619 to 627 of the human glycoprotein 100 (gp100), a melanocyte differentiation antigen widely studied in immunology and cancer biology. As a well-characterized epitope, this peptide is notable for its role in antigen presentation and T cell recognition, particularly within the context of melanoma research. Its defined sequence and immunogenic properties make it a vital tool for investigating peptide-MHC interactions, T cell specificity, and immune modulation. Researchers leverage its biochemical stability and sequence fidelity to probe mechanisms of antigen processing and adaptive immune responses.

Immunological assay development: The gp100 (619-627) peptide is frequently utilized in the design and optimization of immunological assays, such as enzyme-linked immunospot (ELISpot) and intracellular cytokine staining. By serving as a defined antigenic stimulus, it enables the quantification and characterization of antigen-specific CD8+ T cells, facilitating the assessment of cellular immune responses in experimental models. Its use in these assays aids in dissecting the dynamics of T cell activation and functional avidity, contributing to a deeper understanding of immune recognition in the context of melanoma-associated antigens.

Epitope mapping and T cell specificity studies: As a well-defined MHC class I-restricted epitope, this peptide is instrumental in mapping T cell receptor (TCR) specificity and cross-reactivity. Researchers employ it to identify and characterize T cell clones with reactivity against gp100, enabling detailed analysis of TCR-peptide-MHC interactions. These studies provide valuable insights into the determinants of T cell recognition and tolerance, informing the selection of immunogenic epitopes for further research and development.

Peptide-MHC binding investigations: The sequence of gp100 (619-627) is widely used in studies exploring peptide binding affinity and stability with major histocompatibility complex (MHC) molecules. By assessing its interaction with specific MHC alleles, scientists can elucidate the structural and biochemical factors governing antigen presentation. This knowledge supports the rational design of peptide-based reagents and the prediction of immunogenicity for related epitopes.

Functional analysis of antigen processing: The peptide is also used as a benchmark substrate in experiments designed to evaluate antigen processing pathways. By comparing the presentation of the synthetic fragment to endogenously processed antigens, researchers can dissect the efficiency and fidelity of proteasomal cleavage, transporter associated with antigen processing (TAP) translocation, and MHC class I loading. These investigations are critical for understanding the molecular basis of antigen presentation and immune surveillance.

Adoptive T cell research: In adoptive cell transfer and T cell engineering studies, gp100 (619-627) serves as a model antigen for validating the specificity and activity of genetically modified T cells. Its use allows for the precise assessment of T cell receptor function, cytotoxicity, and cytokine production in response to a defined target. This application is essential for advancing the development of T cell-based immunological tools and for evaluating the safety and efficacy of experimental cellular therapies in preclinical research settings.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

4. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

5. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I